Welcome to our dedicated page for MSP Recovery SEC filings (Ticker: MSPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MSP Recovery, Inc. filings document the company's reimbursement recovery business and its public-company capital structure. Recent Form 8-K reports center on material definitive agreements involving subsidiary funding arrangements, working capital credit facility disclosures and operating-expense financing. The filings identify Class A common stock and redeemable warrants traded on the OTC Market Group under MSPR, MSPRW and MSPRZ.
The company's regulatory record also includes reporting-status disclosures, including a Form 12b-25 notification related to a delayed annual report. Those filings describe liquidity constraints, reliance on loan funding, evaluation of financing and reorganization alternatives, and risks around continued reporting. Periodic reports and current reports provide formal disclosure on governance, capital structure, material agreements, risk factors and the financial reporting framework for MSP Recovery's recovery and technology operations.
MSP Recovery, Inc. filed a prospectus supplement registering the resale of up to 56,896 shares of Class A Common Stock by selling securityholders, including shares issuable upon exercise of warrants and shares issued as consideration. The supplement attaches a Form 8-K that discloses two one-time advances of $0.1 million each from Hazel Partners Holdings LLC and VRM MSP Recovery Partners, LLC to support operations and accounts payable. The supplement notes a 1-for-7 reverse stock split effective September 1, 2025, and provides closing market prices as of May 5, 2026. The exercise price for certain warrants is $0.0175 per share, so any proceeds from those exercises would be nominal.
MSP Recovery, Inc. entered two small, one-time funding arrangements that highlight its constrained liquidity. Through a Hazel Partners Holdings LLC letter agreement, the company received a $0.1 million discretionary advance under its existing working capital credit facility, increasing prior Operational Collection Floor advances of about $6.0 million. The facility remains fully discretionary, provides no committed liquidity, and offers no additional availability beyond this single advance.
The company also signed an Advance Letter with VRM MSP Recovery Partners, LLC, under which VRM provided a separate $0.1 million one-time advance of recovery proceeds to support accounts payable. MSP Recovery must reimburse VRM for this advance and certain prior consents upon closing any future financing, including potential debtor-in-possession financing if it operates under Chapter 11 protection. Both agreements expressly state there is no obligation for further funding and caution that these advances should not be viewed as evidence of future liquidity.
MSP Recovery, Inc. registers 56,896 shares of Class A Common Stock for resale under its S-1 prospectus supplement. The supplement breaks the offering into warrants-related issuances and shares issued for services, and notes a 1-for-7 reverse split effective September 1, 2025.
The filing also attaches a Current Report describing two one-time $0.1 million advances: a Hazel discretionary Operational Collection Floor advance and a VRM advance to support accounts payable; both advances are described as standalone accommodations.
MSP Recovery, Inc. files a prospectus supplement registering 285,715 shares of Class A Common Stock for resale by YA II PN, Ltd. (Yorkville) under a previously disclosed Standby Equity Purchase Agreement (the "Yorkville SEPA"). The supplement incorporates a Form 8-K describing updates to the Yorkville arrangements and short-term lender advances.
The Yorkville SEPA permits the Company to sell shares to Yorkville (up to $250 million in aggregate issuances subject to an Ownership Limitation and other caps), and Yorkville holds convertible notes and advance rights described in the supplement. The prospectus notes the Company will not receive proceeds from Yorkville's resale activity; proceeds to the Company may arise only from shares it elects to sell to Yorkville under the SEPA.
MSP Recovery, Inc. filed Prospectus Supplement No. 65 to its S-1 registering up to 909,982 shares of Class A common stock and related resale rights in connection with private and dividend-issued warrants and other legacy instruments. The supplement incorporates an April 16, 2026 Current Report on Form 8-K that discloses two one-time advances of $0.1 million each from Hazel Partners Holdings, LLC and VRM MSP Recovery Partners, LLC to support operating needs and accounts payable. The prospectus notes adjusted warrant economics after the Business Combination, including Public Warrant exercise price of $0.4375 and New Warrant exercise price of $50,312.50, and reports an April 17, 2026 closing common share price of $0.0382. The filing emphasizes that the New Warrants are unlikely to be cash-exercised at current market prices and that the advances are one-time accommodations, with no committed further funding under the working capital facility or from VRM.
MSP Recovery, Inc. files Prospectus Supplement No. 58 to register the resale of up to 32,220 shares of Class A Common Stock by selling securityholders.
The supplement specifies that up to 15,239 shares are issuable upon exercise of a warrant held by Brickell Key Investments LP (the “CPIA Warrant”) at an exercise price of $0.4375 per share, which would yield only nominal proceeds to the company if exercised. The supplement incorporates a Form 8-K disclosing two one-time advances of $0.1 million each from Hazel Partners Holdings, LLC and VRM MSP Recovery Partners, LLC, and notes a prior 1-for-7 reverse stock split effective September 1, 2025. Closing market quotes on April 17, 2026 are included for common stock and warrants.
MSP Recovery, Inc. obtained two small, one-time funding arrangements totaling $0.2 million on April 16, 2026, highlighting near-term liquidity pressure. Through its Hazel Partners working capital credit facility, Hazel agreed in its sole discretion to provide a $0.1 million advance primarily for operating expenses, funded under the discretionary Operational Collection Floor.
The company also entered a letter agreement with VRM MSP Recovery Partners, LLC, which provided a one-time advance of recovery proceeds of $0.1 million to support accounts payable, to be reimbursed from any future financing, including potential debtor-in-possession financing if the company operates under Chapter 11 protection. MSP Recovery emphasizes that these advances do not create ongoing access to liquidity, and it has no rights or reasonable basis to expect further funding from Hazel or VRM.
MSP Recovery, Inc. amends its May 4, 2024 prospectus to register the resale of up to 32,220 shares of Class A Common Stock. The resale pool includes up to 15,239 shares issuable upon exercise of a warrant (the CPIA Warrant); the exercise price is $0.4375 per share, meaning the company would receive only nominal proceeds if exercised. The supplement attaches a Form 8-K disclosing two one-time advances of $0.1 million each from Hazel Partners and VRM to support operations and accounts payable. The company completed a 1-for-7 reverse split effective September 1, 2025, and share figures in this supplement are adjusted for that split.
MSP Recovery, Inc. files a Prospectus Supplement updating its resale prospectus to register 56,896 shares of Class A Common Stock for resale by selling securityholders. The supplement incorporates an attached Form 8-K that discloses two one-time advances of $0.1 million each from Hazel Partners Holdings, LLC and VRM MSP Recovery Partners, LLC to support operating needs and accounts payable. The filing notes the exercise price of certain warrants is $0.0175 per share and gives April 3, 2026 closing-market quotes; it also states a 1-for-7 reverse stock split became effective September 1, 2025. The advances are described as discrete accommodations and do not create ongoing funding commitments.
MSP Recovery, Inc. filed Prospectus Supplement No. 59 registering 285,715 shares of Class A common stock for potential resale or issuance to YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement (the “Yorkville SEPA”). The supplement attaches a Form 8-K that discloses recent amendments to the Yorkville facility, multiple Convertible Notes advances and conversion terms, reductions to the SEPA Floor Price down to $0.50, a Nasdaq delisting and transition to OTCQB, and two one-time short-term advances of $0.1 million each from Hazel and VRM to support operations. The Yorkville SEPA provides up to $250 million of issuance capacity subject to an Ownership Limitation (9.99%) and previously an Exchange Cap that was lifted effective January 8, 2025. The company states it will not receive proceeds from Yorkville’s resale activity, though it may elect to sell shares to Yorkville under the SEPA.